Skip to content

Clinical trials

Graves Ophthalmopathy trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graves Ophthalmopathy Country / region: Italy Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20161
20171
20182
20192
20203
20211
20223
20233
20246
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting4
Terminated4
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pisa8
Amgen6
Immunovant Sciences GmbH3
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico2
argenx2
Hoffmann-La Roche1
Sling Therapeutics, Inc.1
Tourmaline Bio, Inc., a Novartis Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graves Ophthalmopathy24
Graves Disease4
Exophthalmos3
Eye Diseases3
Autoimmune Diseases2
Hypercholesterolemia2
Hyperthyroidism2
Thyroid Diseases2
Endocrine System Diseases1
Hashimoto Disease1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.